help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keeney, D. S.
Right arrow Articles by Ewing, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keeney, D. S.
Right arrow Articles by Ewing, L. L.

Endocrinology, Vol 123, 2906-2915, Copyright © 1988 by Endocrine Society


ARTICLES

Effect of long term deprivation of luteinizing hormone on Leydig cell volume, Leydig cell number, and steroidogenic capacity of the rat testis

DS Keeney, SM Mendis-Handagama, BR Zirkin and LL Ewing
Department of Population Dynamics, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205.

Leydig cells atrophy, losing cytoplasmic volume and the capacity for testosterone secretion, within 1-2 weeks of LH deprivation. We investigated the effects of long term (0-16 weeks) LH deprivation on the volume of an average Leydig cell, the volume of Leydig cells per testis, the number of Leydig cells per testis, and testosterone secretion by in vitro perfused testes. Endogenous LH was suppressed in adult rats by testosterone/estradiol-filled (TE) Silastic implants. The presence of Leydig cells in testes was verified by 1) morphological examination using light and electron microscopy, 2) histochemical localization of 3 beta-hydroxysteroid dehydrogenase activity (3 beta HSD), and 3) conversion of pregnenolone to progesterone by in vitro perfused testes. Marked quantitative differences existed in Leydig cell morphology among control and treated rats. The volume of an average Leydig cell and the total volume of Leydig cells per testis decreased (P less than 0.01) rapidly and progressively after TE implantation. At 16 weeks, the average Leydig cell lost 90% of its cytoplasmic volume and 65% of its nuclear volume. Analysis of variance failed to detect a significant decline in Leydig cell number per testis, despite a 16% reduction from the value in control rats (22.2 +/- 1.5 x 10(6)) in rats treated for 16 weeks (18.7 +/- 1.5 x 10(6)). After TE implantation, LH- stimulated testosterone secretion by in vitro perfused testes diminished (P less than 0.01) rapidly to 5% of the control values at 1 week and less than 0.3% of the control value from 4-16 weeks. In contrast, 25% of 3 beta HSD activity was retained (P less than 0.01 vs. controls) at 16 weeks, based on the rate of pregnenolone conversion to progesterone. Moreover, testes of treated rats secreted progesterone at a rate twice that of controls, when the steroid secretion rates were expressed per volume of Leydig cell cytoplasm. Loss of the testosterone- secreting capacity of testes after LH withdrawal was associated with a loss in the volume, but not a significant loss in the number, of Leydig cells. Thus, LH was required to maintain the differentiated structure and function of Leydig cells, but was not required to maintain the overwhelming majority of Leydig cells in the adult rat testis through 16 weeks. Moreover, at least one steroidogenic enzyme, 3 beta HSD, was retained by Leydig cells after long term LH deprivation.


This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Chen, J. Liu, L. Luo, and B. R. Zirkin
Dibutyryl Cyclic Adenosine Monophosphate Restores the Ability of Aged Leydig Cells to Produce Testosterone at the High Levels Characteristic of Young Cells
Endocrinology, October 1, 2004; 145(10): 4441 - 4446.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. Wang and M. P. Hardy
Development of Leydig Cells in the Insulin-Like Growth Factor-I (IGF-I) Knockout Mouse: Effects of IGF-I Replacement and Gonadotropic Stimulation
Biol Reprod, March 1, 2004; 70(3): 632 - 639.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. S. Calikoglu
Adrenocorticotropic Hormone, a New Player in the Control of Testicular Steroidogenesis
Endocrinology, August 1, 2003; 144(8): 3277 - 3278.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Broqua, P. J.-M. Riviere, P. M. Conn, J. E. Rivier, M. L. Aubert, and J.-L. Junien
Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. M. Lei, S. Mishra, W. Zou, B. Xu, M. Foltz, X. Li, and Ch. V. Rao
Targeted Disruption of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Gene
Mol. Endocrinol., January 1, 2001; 15(1): 184 - 200.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
B. R. Zirkin and H. Chen
Regulation of Leydig Cell Steroidogenic Function During Aging
Biol Reprod, October 1, 2000; 63(4): 977 - 981.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Chen and B. R. Zirkin
Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging
PNAS, December 21, 1999; 96(26): 14877 - 14881.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Hakola, D. D. Pierroz, A. Aebi, B. A.M. Vuagnat, M. L. Aubert, and I. Huhtaniemi
Dose and Time Relationships of Intravenously Injected Rat Recombinant Luteinizing Hormone and Testicular Testosterone Secretion in the Male Rat
Biol Reprod, August 1, 1998; 59(2): 338 - 343.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society